Bronchitis, Chronic Clinical Trial
Official title:
A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Levofloxacin for the Treatment of Acute Exacerbation of Chronic Bronchitis (AECB)
This study was performed to confirm that a single 2.0-g dose of azithromycin SR is at least as effective as 7 days of levofloxacin 500 mg/day in adults with acute exacerbation of chronic bronchitis Secondary objectives: To assess safety and the bacteriologic efficacy of both treatment regimens
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT00245453 -
Outpatient Registry Trial of Respiratory Tract Infections in Adults
|
Phase 4 | |
Completed |
NCT00473460 -
Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis
|
Phase 3 | |
Completed |
NCT00649831 -
A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis
|
Phase 3 | |
Completed |
NCT01507415 -
Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?
|
N/A | |
Active, not recruiting |
NCT00608764 -
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
|
||
Completed |
NCT00538148 -
Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD
|
Phase 4 | |
Completed |
NCT02637219 -
Innate Immune Response in COPD
|
N/A | |
Completed |
NCT00406705 -
The Effect of Breathing Helium-Hyperoxia During Pulmonary Rehabilitation in Patients With COPD
|
Phase 2 | |
Completed |
NCT00257140 -
A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria
|
Phase 2/Phase 3 | |
Completed |
NCT01719822 -
Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
|
N/A | |
Terminated |
NCT02261350 -
Post-hospitalisation Nutritional Support and Gait Speed in COPD
|
Phase 3 | |
Completed |
NCT01495780 -
eRT Remote Health Monitoring
|
N/A | |
Completed |
NCT01077102 -
Eccentric Exercise Training as Novel Rehabilitation for Chronic Obstructive Pulmonary Disease (COPD)
|
N/A | |
Terminated |
NCT00288223 -
Telithromycin in Acute Exacerbation of Chronic Bronchitis
|
Phase 4 | |
Completed |
NCT00423137 -
Effect of BIBW 2948 BS in COPD
|
Phase 2 | |
Completed |
NCT02483637 -
Safety and Feasibility Study of Rejuvenairâ„¢ for Treating Chronic Bronchitis Patients
|
N/A | |
Completed |
NCT00932802 -
Greatest International Antiinfective Trial With Avelox
|
N/A | |
Completed |
NCT00245427 -
Outcomes of Patients Not Responding to Antibiotics in the Community
|
N/A | |
Completed |
NCT00035828 -
A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD
|
Phase 2 | |
Completed |
NCT00184977 -
COPD on Primary Care Treatment (COOPT)
|
Phase 4 |